Quantitation of TG levels revealed that overexpressing JMJD2B increased intracellular TG levels in HepG2 cells (Fig. 2B), suggesting that JMJD2B contributes to the induction of hepatic steatosis. Here, KDM4B is linked to fatty liver disease.